Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand.

Saved in:
Bibliographic Details
Title: Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand.
Authors: Chepulis L; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand. Lynnec@waikato.ac.nz., Rodrigues M; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Gan H; School of Computing and Mathematical Scienes, University of Waikato, Hamilton, New Zealand., Keenan R; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Kenealy T; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Murphy R; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Health New Zealand / Te Whatu Ora Te Toka Tumai, Auckland, New Zealand., Karu LT; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Scott-Jones J; Midlands Health Network, Hamilton, New Zealand., Clark P; Northcare Medical Centre, Hamilton, New Zealand., Moffitt A; Procare Health Limited, Auckland, New Zealand., Mustafa S; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Lawrenson R; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand., Paul R; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.; Health New Zealand / Te Whatu Ora Waikato, Hamilton, New Zealand.
Source: BMC health services research [BMC Health Serv Res] 2025 Mar 26; Vol. 25 (1), pp. 433. Date of Electronic Publication: 2025 Mar 26.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40140836
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chepulis+L%22">Chepulis L</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand. Lynnec@waikato.ac.nz.<br /><searchLink fieldCode="AU" term="%22Rodrigues+M%22">Rodrigues M</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Gan+H%22">Gan H</searchLink>; School of Computing and Mathematical Scienes, University of Waikato, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Keenan+R%22">Keenan R</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Kenealy+T%22">Kenealy T</searchLink>; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Murphy+R%22">Murphy R</searchLink>; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Health New Zealand / Te Whatu Ora Te Toka Tumai, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Karu+LT%22">Karu LT</searchLink>; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Scott-Jones+J%22">Scott-Jones J</searchLink>; Midlands Health Network, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Clark+P%22">Clark P</searchLink>; Northcare Medical Centre, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Moffitt+A%22">Moffitt A</searchLink>; Procare Health Limited, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Mustafa+S%22">Mustafa S</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Lawrenson+R%22">Lawrenson R</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.<br /><searchLink fieldCode="AU" term="%22Paul+R%22">Paul R</searchLink>; Waikato Medical Research Centre, University of Waikato, Private Bag 3105, Hamilton, New Zealand.; Health New Zealand / Te Whatu Ora Waikato, Hamilton, New Zealand.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101088677%22">BMC health services research</searchLink> [BMC Health Serv Res] 2025 Mar 26; Vol. 25 (1), pp. 433. <i>Date of Electronic Publication: </i>2025 Mar 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101088677 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-6963 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214726963%22">14726963 </searchLink><i>NLM ISO Abbreviation: </i>BMC Health Serv Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40140836
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12913-025-12601-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 433
    Titles:
      – TitleFull: Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New Zealand.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chepulis L
      – PersonEntity:
          Name:
            NameFull: Rodrigues M
      – PersonEntity:
          Name:
            NameFull: Gan H
      – PersonEntity:
          Name:
            NameFull: Keenan R
      – PersonEntity:
          Name:
            NameFull: Kenealy T
      – PersonEntity:
          Name:
            NameFull: Murphy R
      – PersonEntity:
          Name:
            NameFull: Karu LT
      – PersonEntity:
          Name:
            NameFull: Scott-Jones J
      – PersonEntity:
          Name:
            NameFull: Clark P
      – PersonEntity:
          Name:
            NameFull: Moffitt A
      – PersonEntity:
          Name:
            NameFull: Mustafa S
      – PersonEntity:
          Name:
            NameFull: Lawrenson R
      – PersonEntity:
          Name:
            NameFull: Paul R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 03
              Text: 2025 Mar 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1472-6963
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC health services research
              Type: main
ResultId 1